KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers Meeting Abstract
| Authors: | Kirtane, K.; Massarelli, E.; Hanna, G. J.; Klebanoff, C. A.; Blumenschein, G.; Bishop, M. R.; Lee, S.; Niu, J.; Adhikary, S.; Astrow, S. H.; Rodriguez, K.; Chu, R.; Jung, A. S. |
| Abstract Title: | KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309066 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS3149 |
| Notes: | Meeting Abstract: TPS3149 -- Source: Wos |
